Furthermore, we have studied HMGB1 in the context of MS on account of its excessive expression and production of HMGB1 from progenitor cells which exhibit a cellular senescent phenotype (Davalos et al., 2013; Nicaise et al., 2019). This evidence concerns the gene HMGB1 and myeloid sarcoma.